文献速递消化道肿瘤与早癌

嗜热链球菌通过分泌β-半乳糖苷酶抑制结直肠肿瘤发生

Streptococcus thermophilus Inhibits Colorectal Tumorigenesis Through Secreting β-Galactosidase.
PubMed 文献 · Gastroenterology · 2020-09-11

对526份多队列粪便样本的鸟枪法宏基因组测序发现结直肠癌患者中嗜热链球菌减少。该菌在两种小鼠肠道肿瘤模型中的抗肿瘤作用及其分泌的β-半乳糖苷酶机制被评估,结果显示该菌通过β-半乳糖苷酶抑制肿瘤形成。

要点

  • 嗜热链球菌灌胃显著减少Apcmin/+和氧化偶氮甲烷注射小鼠的肿瘤形成。
  • β-半乳糖苷酶是嗜热链球菌发挥抑瘤作用的关键蛋白。
  • 无功能性β-半乳糖苷酶的突变株丧失抑瘤效果。

核心结论

  • 嗜热链球菌是小鼠中一种新型的结直肠癌预防性制剂。
  • 其抑瘤作用至少部分由分泌β-半乳糖苷酶所介导。

研究设计与样本

  • 研究采用培养结肠上皮细胞和两种小鼠肠道肿瘤模型评估嗜热链球菌的抗肿瘤作用。
  • 通过质谱和β-半乳糖苷酶活性测定鉴定抑瘤蛋白,并用同源重组构建突变株。
  • 通过鸟枪法宏基因组测序评估嗜热链球菌对肠道菌群组成的影响。

主要发现

  • 口服灌胃嗜热链球菌显著减少Apcmin/+和氧化偶氮甲烷注射小鼠的肿瘤形成。
  • 与嗜热链球菌或其条件培养基共孵育降低培养结直肠癌细胞的增殖。
  • β-半乳糖苷酶被鉴定为嗜热链球菌产生的关键蛋白。
  • 嗜热链球菌分泌的β-半乳糖苷酶抑制细胞增殖、降低集落形成、诱导细胞周期阻滞、促进培养结直肠癌细胞凋亡并延缓结直肠癌异种移植瘤生长。
  • 无功能性β-半乳糖苷酶的突变嗜热链球菌丧失抑瘤效果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Streptococcus thermophilus was identified to be depleted in patients with colorectal cancer (CRC) by shotgun metagenomic sequencing of 526 multicohort fecal samples. Here, we aim to investigate whether this bacterium could act as a prophylactic for CRC prevention. METHODS: The antitumor effects of S thermophilus were assessed in cultured colonic epithelial cells and in 2 murine models of intestinal tumorigenesis. The tumor-suppressive protein produced by S thermophilus was identified by mass spectrometry and followed by β-galactosidase activity assay. The mutant strain of S thermophilus was constructed by homologous recombination. The effect of S thermophilus on the gut microbiota composition was assessed by shotgun metagenomic sequencing. RESULTS: Oral gavage of S thermophilus significantly reduced tumor formation in both Apcmin/+ and azoxymethane-injected mice. Coincubation with S thermophilus or its conditioned medium decreased the proliferation of cultured CRC cells. β-Galactosidase was identified as the critical protein produced by S thermophilus by mass spectrometry screening and β-galactosidase activity assay. β-Galactosidase secreted by S thermophilus inhibited cell proliferation, lowered colony formation, induced cell cycle arrest, and promoted apoptosis of cultured CRC cells and retarded the growth of CRC xenograft. The mutant S thermophilus without functional β-galactosidase lost its tumor-suppressive effect. Also, S thermophilus increased the gut abundance of known probiotics, including Bifidobacterium and Lactobacillus via β-galactosidase. β-Galactosidase-dependent production of galactose interfered with energy homeostasis to activate oxidative phosphorylation and downregulate the Hippo pathway kinases, which partially mediated the anticancer effects of S thermophilus. CONCLUSION: S thermophilus is a novel prophylactic for CRC prevention in mice. The tumor-suppressive effect of S thermophilus is mediated at least by the secretion of β-galactosidase.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Li Q, Hu W, Liu WX, et al. Streptococcus thermophilus Inhibits Colorectal Tumorigenesis Through Secreting β-Galactosidase. Gastroenterology. 2020. PMID: 32920015. doi:10.1053/j.gastro.2020.09.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。